Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

RESTANCE Announces Contract to Manufacture Playboy Condoms for Distribution in Africa in Support of $20 Million World AIDS Day Campaign

RESTANCE
Posted on: 30 Nov 17

SPARKS, Nevada, November 28, 2017 /PRNewswire/ --

RESTANCE, Inc. (USOTC: ANCE) today announced a contract to manufacture condoms with the Playboy brand name and bunny head logo for distribution, starting in Kenya. The brand name is being announced today in support of World AIDS Day, coming on December 1, 2017. RESTANCE is participating in a campaign to contribute to the United Nations goal of ending the AIDS Epidemic by making condoms available everywhere in Africa through the #DoIt4Africa buy-one-give-one campaign where an anticipated $20 million in condoms will be sold in North America and for every condom sold, a condom will be manufactured in Africa and given away in Africa. RESTANCE has executed an initial $500,000 contract to produce condoms for the campaign. Look for more details on the #DoIt4Africa campaign coming soon.

In addition to opening a condom manufacturing plant, RESTANCE is pursuing several other business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.

Learn more about the RESTANCE operations in Africa on the Company's website: http://www.restanceinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Randell Torno
ir@restanceinc.com 
+1-800-834-5792

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.